Missouri gets 693K in Pfizer settlement
Friday, August 8, 2014 | 1:49 p.m. CDT;
updated 4:30 p.m. CDT, Friday, August 8, 2014
JEFFERSON CITY — Missouri will receive $693,000 part of a $35 million settlement with a Pfizer Inc. subsidiary over the marketing of an organ-transplant drug.
Forty-one states and the District of Columbia reached the deal with the drug maker over charges that Wyeth Pharmaceuticals trained its sales representatives to encourage doctors to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.
Pfizer bought Wyeth in 2009. The company agreed to pay nearly $491 million in July 2013 to resolve a similar investigation by the Department of Justice.
New York-based Pfizer said in a statement the alleged activity occurred before it acquired Wyeth. Pfizer didn't admit wrongdoing or liability as part of the settlement.
Like what you see here? Become a member.
Report corrections or additions here. Leave comments below here.
You must be logged in to participate in the Show Me the Errors contest.
Leave a comment
Speak up and join the conversation! Make sure to follow the guidelines
outlined below and register with our site.
You must be logged in to comment. (Our
full comment policy is here.)
- Don't use obscene, profane or vulgar language.
- Don't use language that makes personal attacks on fellow commenters or
discriminates based on race, religion, gender or ethnicity.
- Use your real first and last name when registering on the website. It will
be published with every comment.
(Read why we ask for that here.)
- Don’t solicit or promote businesses.
We are not able to monitor every comment that comes through. If you see
something objectionable, please click the "Report comment" link.
You must be logged in to comment.